CTA 056
Chemical Name: 1,5-Dihydro-7-(phenylmethyl)-1-[3-(1-piperidinyl)propyl]-2-[4-(4-pyridinyl)phenyl]-6H-imidazo[4,5-g]quinoxalin-6-one
Purity: ≥98%
Biological Activity
CTA 056 is an interleukin-2-inducible T-cell kinase (ITK) inhibitor (IC50 values are 0.1, 0.4 and 5 μM for ITK, BTK and ETK, respectively). Inhibits growth of cancer cells expressing ITK, including MOLT-4 and Jurkat cells in vitro. Induces apoptosis in Jurkat cells. Inhibits MOLT-4 xenograft tumor growth in mice.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for CTA 056
The citations listed below are publications that use Tocris products. Selected citations for CTA 056 include:
1 Citation: Showing 1 - 1
-
High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions.
Authors: Mues Et al.
Cell Rep 2019;27:631
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for CTA 056
There are currently no reviews for this product. Be the first to review CTA 056 and earn rewards!
Have you used CTA 056?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image